Clinical Cancer Research (CCR) is a scholarly journal dedicated to publishing research in the field of Medicine. American Association for Cancer Research is the publisher of this esteemed journal. The P-ISSN assigned to Clinical Cancer Research is 1078-0432 and its abbreviated form is Clin Cancer Res.
Clinical Cancer Research publishes innovative clinical and translational cancer research studies that bridge the laboratory and the clinic. The Journal is especially interested in clinical trials evaluating new treatments, accompanied by research on pharmacology, and molecular alterations or biomarkers that predict response or resistance to treatment. The Journal also prioritizes laboratory and animal studies of new drugs and molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease.
Specific areas of interest include clinical and translational research in targeted therapies; mechanisms of drug sensitivity and resistance; pharmacogenetics and pharmacogenomics; personalized medicine; novel applications of bioinformatics and biostatistics; immunotherapy and clinical immunology; gene therapy; radiobiology and radiation oncology; large-scale molecular characterization of human tumors; diagnostic biomarkers; innovative imaging and other novel methods with potential applicability to clinical investigation; clinical genetics; and detection of minimal disease.
| Journal title | Clinical Cancer Research (CCR) |
| Abbreviation | Clin Cancer Res |
| Print ISSN | 1078-0432 |
| Online ISSN | 1557-3265 |
| Publisher Name | American Association for Cancer Research |
| Editor-in-chief | Keith T. Flaherty |
| Subject Category | Medicine |
Clinical Cancer Research Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Clinical Cancer Research Journal is Clin Cancer Res.
The Ranking of Clinical Cancer Research in 2026 is 305. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.
The Impact Factor of Clinical Cancer Research in 2026 is 11.5. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.
The SCImago of Clinical Cancer Research in 2026 is 4.603. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.
The Acceptance Rate of Clinical Cancer Research in 2026 is 20%. It is a measure that provides insight into the selectivity and competitiveness of a journal's editorial process.
The H-Index of Clinical Cancer Research in 2026 is 362. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.
The Quartile of Clinical Cancer Research is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.
The Clinical Cancer Research is indexed in (Indexing details)
| PubMed | Scopus | Web of Science | UGC | Embase | DOAJ |
|---|---|---|---|---|---|
| ✅ | ✅ | ✅ | ✅ | ❌ | ❌ |
Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.
| Abbreviation | Clin Cancer Res |
| Access type | Hybrid |
| Acceptance rate | 20% |
| Impact Factor | 11.5 |
| SJR | 4.603 |
| SNIP | 2.156 |
| Ranking | 305 |
| CiteScore | 21.8 |
| H-Index | 362 |
The Editor-in-chief of Clinical Cancer Research is Keith T. Flaherty
Clinical Cancer Research Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.
The APC/Submission (Publication) Fee of Clinical Cancer Research is $2,300
Clinical Cancer Research Call for paper : Clinical Cancer Research invites original research contributions for consideration of publication in Clinical Cancer Research journal.
Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.
for details about call for paper please visit to the official website of the journal to check the details about call for papers.
Publishing in Clinical Cancer Research involves the following steps:
Yes, the Clinical Cancer Research journal is indexed in PubMed.
Yes, the Clinical Cancer Research journal is indexed in Scopus.
Yes, the Clinical Cancer Research journal is indexed in UGC.
No, the Clinical Cancer Research journal is not indexed in Index copernicus.
No, Clinical Cancer Research journal is not a predatory journal.
The Impact Factor of the Clinical Cancer Research is 11.5.
The Ranking of the Clinical Cancer Research is 305.
Yes the Clinical Cancer Research (CCR) journal is a peer-reviewed journal.
Yes the Clinical Cancer Research journal is a peer-reviewed journal and good to publish your paper.
Clinical Cancer Research (CCR) is a scholarly journal dedicated to publishing research in the field of Medicine. American Association for Cancer Research is the publisher of this esteemed journal.
Yes, Clinical Cancer Research is a open access (Hybrid) journal.